Top 15 Influenza Vaccine Companies in the World: Leaders in Global Health

This growth is expected to continue, with projections indicating that the market could reach around US$ 9.66 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 8% from 2025 – 2033.
 
DELHI, India - Oct. 28, 2024 - PRLog -- United States Influenza Vaccines Market Competitive Landscape

The influenza vaccines market in the United States is characterized by the presence of several key players, each contributing to the competitive landscape through distinct strategies and market shares. The leading manufacturers include prominent pharmaceutical companies such as GlaxoSmithKline, Sanofi Pasteur, AstraZeneca and Seqirus, which together dominate a significant portion of the market. As of 2024, these companies hold an aggregate market share exceeding XX%, driven by their extensive product portfolios and robust distribution networks.

The competitive strategies employed by manufacturers, including pricing models, promotional activities, and collaborations with healthcare entities, are instrumental in shaping the dynamics of the influenza vaccines market in the United States.

Top and Emerging Player's Profiles
  • Sanofi Pasteur
  • GlaxoSmithKline (GSK)
  • Seqirus (CSL Limited)
  • AstraZeneca
  • Novavax
  • Medicago
  • Moderna Inc
  • Pneumagen
  • Daiichi–Sankyo
  • Altimmune
  • FluGen
  • Imutex
  • EpiVax, Inc
  • Versatope Therapeutics, Inc
  • BiondVax Pharmaceuticals Ltd.
More Information: https://dpiresearch.com/report/united-states-influenza-va...

Contact
Maria Rai
sales@dpiresearch.com
***@dpiresearch.com
End
Source: » Follow
Email:***@dpiresearch.com Email Verified
Tags:Vaccine Companies
Industry:Business
Location:Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share